New task order alcohol CUE human laboratory study testing apremilast. Contractor to serve as a clinical research site for a multiple-site clinical trial to test apremilast for the treatment of alcohol…
Active Awarded Last action
- Contract number
- 75N94025F00002
- Awardee
-
Rector & Visitors Of The University Of Virginia UEI JJG6HU8PA4S5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $682,868
Award facts
- Opportunity
-
- NIAAACSHLAB004 Solicitation number
- Contract value 100% obligated
- $682,868.00 Current and potential, with all options
- Completion date 94% complete
- Current and potential, with all options
- Funding agency
- National Institute on Alcohol Abuse and Alcoholism National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Charlottesville, VA 22904, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for a new task order with the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, to support a multiple-site clinical trial testing the drug apremilast for the treatment of alcohol use disorder. The prime contractor is the Rector & Visitors of the University of Virginia (UVA), a non-profit organization and educational institution. The contract is not set aside and has a ceiling value of $682,868.00. It is a delivery order under the larger "Clinical Research Sites for the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder" contract vehicle. The contract will run through November 17, 2026, with the award date of September 18, 2025. As a major research university, UVA has extensive experience supporting federal agencies through contract and grant work across various scientific domains.
Description
New task order alcohol CUE human laboratory study testing apremilast. Contractor to serve as a clinical research site for a multiple-site clinical trial to test apremilast for the treatment of alcohol use disorder.
Quick answers
Who was awarded contract 75N94025F00002?
75N94025F00002 was awarded to Rector & Visitors Of The University Of Virginia by National Institute of Child Health and Human Development (National Institutes of Health) on September 18, 2025.
How much is contract 75N94025F00002 worth?
The government has obligated $682,868 on 75N94025F00002.
Which agency awarded contract 75N94025F00002?
National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94025F00002, with funding from National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health).
Is contract 75N94025F00002 an order under another contract?
Yes. 75N94025F00002 is a delivery order under 75N94021D00010, an indefinite delivery contract, on Clinical Research Sites for the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder.
Was contract 75N94025F00002 competed?
The extent of competition for 75N94025F00002 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award